Saleh A. Alkhedhairi
Buraydah, 51452, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Small-molecule disruption of the TRAF6-Ubc13 protein-protein interaction: targeting noncanonical ubiquitin signaling in inflammation and cancer.
Journal: Biochemical pharmacology
Published: July 03, 2026
Combined in vitro optical and in silico docking approaches: evaluating kinetic and thermodynamic parameters in the taurine-albumin complex.
Journal: Methods (San Diego, Calif.)
Published: April 17, 2026
Status of cryptosporidiosis in cattle raised by marginalized nomadic communities of Southern Punjab, Pakistan: an observational study.
Journal: Frontiers in veterinary science
Published: March 02, 2026
Disrupting the tumor-associated TNKS-USP25 protein-protein interface in cancer: structural basis, druggability, and therapeutic opportunities.
Journal: RSC advances
Published: February 15, 2026
Protein-protein interaction disruption as a next-generation antithrombotic strategy.
Journal: Journal of thrombosis and thrombolysis
Published: February 11, 2026
Disrupting the KRAS-SOS1 protein-protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapy.
Journal: Frontiers in chemistry
Published: February 10, 2026
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
Journal: Biochemical pharmacology
Published: January 29, 2026
Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy.
Journal: Discover oncology
Published: January 26, 2026
Recent advances in indole-thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potential.
Journal: Pharmacological reports : PR
Published: January 20, 2026
CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.
Journal: Pathology, research and practice
Published: January 20, 2026
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Journal: Neurochemistry international
Published: January 19, 2026
Disrupting the ASH2L-DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation.
Journal: Epigenetics & chromatin
Published: November 26, 2025
Last Updated: 09/26/2026